Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The complex role of inflammation and gliotransmitters in Parkinson's disease. | Neurobiol Dis | 2023 | 36470499 | PubTator, text mining | PubMed |
| Cellular and molecular responses to ethyl-parathion in undifferentiated SH-SY5Y cells provide neurotoxicity pathway indicators for organophosphorus impacts. | Toxicol Sci | 2023 | 36458919 | PubTator, text mining | PubMed |
| Modifiable contributing factors to COVID-19: A comprehensive review. | Food Chem Toxicol | 2023 | 36450305 | PubTator, text mining | PubMed |
| Single-cell and microarray chip analysis revealed the underlying pathogenesis of ulcerative colitis and validated model genes in diagnosis and drug response. | Hum Cell | 2023 | 36445533 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals correct developmental dynamics and high-quality midbrain cell types by improved hESC differentiation. | Stem Cell Reports | 2023 | 36400027 | PubTator, text mining | PubMed |
| Serotonin-releasing agents with reduced off-target effects. | Mol Psychiatry | 2023 | 36352123 | PubTator, text mining | PubMed |
| Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals. | Genet Med | 2023 | 36318270 | PubTator, text mining | PubMed |
| LYECs: lysosome-enhancing compounds as potential therapeutic approaches for Alzheimer disease. | Autophagy | 2023 | 36215390 | PubTator, text mining | PubMed |
| Pathological and Therapeutic Advances in Parkinson's Disease: Mitochondria in the Interplay. | J Alzheimers Dis | 2023 | 36093711 | PubTator, text mining | PubMed |
| The effects of reserpine on depression: A systematic review. | J Psychopharmacol | 2023 | 36000248 | PubTator, text mining | PubMed |
| Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target. | Curr Top Behav Neurosci | 2023 | 35711029 | PubTator, text mining | PubMed |
| Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role. | IUBMB Life | 2023 | 35689524 | PubTator, text mining | PubMed |
| Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders. | Curr Top Behav Neurosci | 2023 | 35543868 | PubTator, text mining | PubMed |
| A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the SLC18A2 gene. | Int J Neurosci | 2023 | 34078222 | PubTator, text mining | PubMed |
| Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study. | Mol Psychiatry | 2023 | 33981004 | PubTator, text mining | PubMed |
| Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review. | Front Endocrinol (Lausanne) | 2022 | 36814831 | PubTator, text mining | PubMed |
| Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling. | Front Neurosci | 2022 | 36760795 | PubTator, text mining | PubMed |
| Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics. | Front Neurosci | 2022 | 36699535 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Induced Inactivation of the Autism-Risk Gene setd5 Leads to Social Impairments in Zebrafish. | Int J Mol Sci | 2022 | 36613611 | PubTator, text mining | PubMed |
| Significance of Catecholamine Biosynthetic/Metabolic Pathway in SARS-CoV-2 Infection and COVID-19 Severity. | Cells | 2022 | 36611805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=23